Cargando…
Poly(I:C) Potentiates T Cell Immunity to a Dendritic Cell Targeted HIV-Multiepitope Vaccine
Cellular immune responses are implicated in resistance to HIV and have been considered for the development of an effective vaccine. Despite their safety profile, subunit vaccines need to be delivered combined with an adjuvant. In the last years, in vivo antigen targeting to dendritic cells (DCs) usi...
Autores principales: | Apostólico, Juliana de Souza, Lunardelli, Victória Alves Santos, Yamamoto, Marcio Massao, Cunha-Neto, Edecio, Boscardin, Silvia Beatriz, Rosa, Daniela Santoro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492566/ https://www.ncbi.nlm.nih.gov/pubmed/31105693 http://dx.doi.org/10.3389/fimmu.2019.00843 |
Ejemplares similares
-
Dendritic Cell Targeting Effectively Boosts T Cell Responses Elicited by an HIV Multiepitope DNA Vaccine
por: Apostólico, Juliana de Souza, et al.
Publicado: (2017) -
HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost
por: Apostólico, Juliana de Souza, et al.
Publicado: (2016) -
Adjuvants: Classification, Modus Operandi, and Licensing
por: Apostólico, Juliana de Souza, et al.
Publicado: (2016) -
STAT3 signaling modulates the immune response induced after antigen targeting to conventional type 1 dendritic cells through the DEC205 receptor
por: Sulczewski, Fernando Bandeira, et al.
Publicado: (2022) -
Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells
por: Lunardelli, Victória Alves Santos, et al.
Publicado: (2023)